开发用于REV-ERBα和REV-ERBβ的放射性体结合试验
Thomas Koelblen1, Elise P Burris1, Thomas P Burris1
1University of Florida Genetics Institute, Gainesville, FL, 32610, USA.
Analytical biochemistry
|April 6, 2025
概括
研究人员开发了第一个用于REV-ERBα和REV-ERBβ核受体的放射性结试验 (RLBA). 这种使用3H-STL1267的新分析方法可以直接检测连接体结合,从而促进对昼夜节律和代谢疾病的药物发现.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- REV-ERBα和REV-ERBβ是调节昼夜节律,炎症和新陈代谢的核受体.
- 血红素是天然的连接体,合成的激动剂和对抗剂是为了治疗目标而开发的.
- 现有的REV-ERB配体的测定依赖于蛋白质-蛋白质相互作用,缺乏直接的配体结合检测.
研究的目的:
- 开发第一个用于REV-ERBα和REV-ERBβ的放射性连体结合试验 (RLBA).
- 为了验证使用新型放射性标记激动剂,3H-STL1267.7验证该试验.
- 提供针对REV-ERB通路的药物发现工具.
主要方法:
- 基于RLBA的闪近距离测试 (SPA) 的开发.
- 使用3H标记的STL1267,是一种强大的REV-ERBα/β激动剂.
- 使用已知的REV-ERB配体进行和和竞争结合试验.
主要成果:
- 3H-STL1267显示了对REV-ERBα (Kd=392 nM) 和REV-ERBβ (Kd=202 nM) 的和结合.
- 在竞争测试中,STL1267显示出高亲和力 (REV-ERBα的Ki=253nM,REV-ERBβ=98nM).
- 该试验成功地区分了STL1267和SR9009的功效,证实了试验有效性.
结论:
- 成功开发了一种针对REV-ERBα和REV-ERBβ的强大且直接的放射性对象结合试验 (RLBA).
- 这种基于SPA的测定为选和表征REV-ERB配体提供了有价值的工具.
- 该试验促进了针对REV-ERB受体用于各种生理过程的药物发现工作.
相关概念视频
Internal Receptors
68.9K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
68.9K
Transducer Mechanism: Nuclear Receptors
1.2K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.2K


